RXRX — RECURSION PHARMACEUTICALS IN
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 362 家机构在其最新 13F 申报中持有 RXRX(RECURSION PHARMACEUTICALS IN),合计申报市值 $1.29B,对应 350.64M 股。按股数计算较上季度增持 7.4%(+22.16M 股),申报市值环比上升 28.6%。持仓集中度较高:前五大持有人占申报市值的 48.2%,前十大的集中度为 65.3%。
与上一季度相比,55 家新建仓位、138 家加仓、101 家减仓、44 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
RECURSION PHARMACEUTICALS IN(RXRX)的主要机构持有人包括 BlackRock Inc、Vanguard Group、ARK Invest,按 13F 申报市值在本页 679 家持有人中排名居前。
RXRX 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 RXRX 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 RXRX 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q3 2026 | 44.75M | $184.80M | 1.07% | 增持 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 263 | 308.28M | $1.27B | +7.7% |
| Q2 2026 | 362 | 350.64M | $1.29B | +7.6% |
| Q1 2026 | 349 | 335.88M | $1.03B | +4.5% |
| Q4 2025 | 341 | 324.56M | $1.33B | +13.6% |
| Q3 2025 | 328 | 313.72M | $1.53B | +4.8% |
| Q2 2025 | 335 | 301.07M | $1.52B | +2.5% |
| Q1 2025 | 336 | 294.24M | $1.55B | +4.2% |
| Q4 2024 | 313 | 289.17M | $1.95B | +3.7% |
表内 8 个季度中,机构持股合计增加 7%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+13.6%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 53.48M | $220.87M | 0.01% | 增持 | |
| 44.75M | $184.80M | 1.07% | 增持 | |
| 35.81M | $147.90M | 0.01% | 增持 | |
| 30.00M | $123.90M | 0.00% | 增持 | |
| 23.00M | $95.01M | 0.00% | 增持 | |
| 18.17M | $75.06M | 0.07% | 减持 | |
| 13.91M | $57.47M | 0.00% | 增持 | |
| 11.44M | $47.25M | 0.00% | 增持 | |
| 8.43M | $34.82M | 0.01% | 减持 | |
| 8.26M | $34.09M | 7.36% | 减持 | |
| 6.22M | $25.71M | 0.00% | 增持 | |
| 4.94M | $20.42M | 0.01% | 减持 | |
| 4.94M | $20.37M | 0.25% | 减持 | |
| 3.55M | $14.67M | 0.01% | 增持 | |
| 3.54M | $14.61M | 0.00% | 增持 | |
| 2.68M | $11.06M | 0.68% | 增持 | |
| 2.50M | $10.31M | 0.10% | 增持 | |
| 2.39M | $9.87M | 0.00% | 新进 | |
| 2.07M | $8.55M | 0.01% | 减持 | |
| 1.91M | $7.90M | 0.00% | 增持 | |
| 1.89M | $7.80M | 0.05% | 增持 | |
| 1.62M | $6.67M | 0.00% | 减持 | |
| 1.09M | $4.51M | 0.06% | 增持 | |
| 954.80K | $3.94M | 0.00% | 增持 | |
| 913.34K | $3.77M | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 13.82M 股 · $50.72M
- Sixth Street Partners Management Company, L.P. 4.14M 股 · $15.19M
- Quadrature Capital Ltd 987.80K 股 · $3.63M
- Sender Co & Partners, Inc. 270.20K 股 · $991.63K
- Jupiter Topco LLC 220.31K 股 · $809.64K
- Soviero Asset Management, LP 200.00K 股 · $734.00K
- ALLSTATE CORP 127.71K 股 · $468.71K
- Caption Management, LLC 90.00K 股 · $330.30K
- Quantitative Investment Management, LLC 88.88K 股 · $326.00K
- VIRGINIA RETIREMENT SYSTEMS ET Al 85.70K 股 · $314.52K
- WCG Wealth Advisors LLC 73.52K 股 · $269.83K
- LaSalle St. Investment Advisors, LLC 68.00K 股 · $249.56K
完全清仓(较上季)
- STATE STREET CORP 卖出 28.49M 股 · $87.47M
- Renaissance Technologies 卖出 2.40M 股 · $7.37M
- CAPITAL FUND MANAGEMENT S.A. 卖出 1.91M 股 · $5.86M
- Mitsubishi UFJ Trust & Banking Corp 卖出 908.46K 股 · $2.79M
- Janus Henderson Group 卖出 220.31K 股 · $675.25K
- Engineers Gate Manager LP 卖出 213.84K 股 · $656.49K
- Havemeyer Place LP 卖出 183.94K 股 · $564.68K
- Virtu Financial LLC 卖出 149.72K 股 · $460.00K
- Brevan Howard Capital Management LP 卖出 133.31K 股 · $409.28K
- Point72 Asset Management 卖出 46.30K 股 · $142.14K
- IEQ CAPITAL, LLC 卖出 40.05K 股 · $122.95K
- Polymer Capital Management (US) LLC 卖出 39.88K 股 · $122.44K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 53.48M | 50.30M | 43.19M | 38.87M | 31.74M | 28.37M | 23.51M | 23.44M | 20.74M | — | — | — | — | — | — | — | — | — | — | — |
| ARK Invest | 44.75M | 41.34M | 40.21M | 37.32M | 33.55M | 32.99M | 34.82M | 32.35M | 32.77M | 28.14M | 24.59M | 20.65M | 6.88M | 4.74M | 3.58M | 3.10M | 3.36M | 2.73M | 2.83M | 2.23M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 35.81M | 31.13M | 22.76M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 30.00M | — | 28.49M | 25.33M | 18.27M | 11.18M | 13.09M | 12.58M | 12.87M | 8.75M | 10.35M | 12.15M | 11.76M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 23.00M | 22.77M | 22.24M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Baillie Gifford & Co | 18.17M | 23.49M | 23.68M | 23.77M | 23.98M | 24.17M | 24.39M | 24.86M | 25.24M | 26.59M | 24.07M | 24.18M | 24.55M | 25.10M | 25.14M | 24.82M | 21.59M | 21.61M | 21.98M | 22.12M |
| Geode Capital Management | 13.91M | 13.82M | 12.28M | 10.93M | 9.62M | 7.78M | 6.44M | 6.09M | 5.43M | 4.78M | 3.45M | 3.33M | 3.14M | 2.81M | 2.74M | 2.61M | 2.33M | 1.51M | 1.29M | 1.29M |
| Fidelity Management & Research (FMR) | 11.44M | 46.36K | 736.65K | 3.24M | 3.23M | 5.58M | 6.85M | 7.07M | 8.36M | 8.19M | 9.26M | 10.90M | 10.69M | 4.56M | 4.76M | 4.47M | 4.25M | 2.84M | 2.15M | 1.53M |
| UBS Group AG | 8.43M | 8.95M | 43.15K | 43.15K | 188.10K | 4.63M | 5.57M | 3.00M | 799.86K | 1.65M | 672.43K | 691.91K | 342.68K | 168.72K | 168.94K | 361.89K | 18.46K | 4.99K | 6.93K | 259.22K |
| MIC Capital Management UK LLP | 8.26M | 9.64M | 9.64M | 9.64M | 9.64M | 9.64M | 9.64M | 9.64M | 8.45M | 8.45M | 8.45M | 8.45M | 8.45M | — | — | — | — | — | — | — |
| Morgan Stanley | 6.22M | 2.74M | 2.19M | 5.66M | 7.29M | 5.69M | 5.01M | 2.86M | 1.88M | 1.77M | 1.96M | 2.58M | 806.62K | 390.23K | 259.37K | 333.17K | 275.94K | 221.70K | 140.60K | 115.50K |
| Sumitomo Mitsui Trust Group, Inc. | 4.94M | 5.51M | 5.42M | 6.22M | 7.47M | 8.17M | 8.48M | 8.98M | 9.77M | 9.99M | 10.36M | 9.20M | 3.52M | — | — | — | — | — | — | — |
| Amova Asset Management Americas, Inc. | 4.94M | 5.51M | 5.42M | 6.22M | 7.47M | 8.17M | 8.41M | 8.91M | 9.69M | 9.93M | 10.36M | 9.20M | 3.52M | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 3.55M | 3.04M | 2.61M | 2.27M | 1.80M | 1.88M | 1.03M | — | — | 94.85K | 377.73K | 252.69K | 234.42K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 3.54M | 3.47M | 3.51M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 2.68M | 2.60M | 2.56M | 2.40M | 1.77M | 911.09K | 387.24K | 200.47K | 82.35K | 40.25K | — | — | — | — | — | — | — | — | — | — |
| Jump Financial, LLC | 2.50M | 1.02M | 889.93K | 661.63K | 555.08K | 1.15M | 592.35K | 13.49K | — | — | — | — | 253.46K | — | — | — | — | — | — | — |
| MFS Investment Management | 2.39M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 950.59K | 1.33M | 1.34M | 1.30M |
| Marshall Wace | 2.07M | 4.71M | 2.88M | 226.61K | 78.26K | 86.31K | 333.61K | — | — | — | 391.52K | — | — | — | 514.14K | — | — | 106.79K | — | — |
| Nuveen, LLC | 1.91M | 1.72M | 1.16M | 1.08M | 1.28M | 1.23M | 1.91M | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold RXRX?
As of 2026-Q2, 362 institutional funds reported holding RXRX (RECURSION PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $1.29B.
How many shares of RXRX do institutions own?
13F filers reported 350.64M shares of RXRX, worth $1.29B in aggregate at the end of 2026-Q2.
Is institutional ownership of RXRX rising or falling?
Share counts moved +7.4% versus the prior quarter — accumulation.
Who are the top institutional holders of RXRX?
The largest 13F holders are BlackRock Inc, Vanguard Group, ARK Invest, VANGUARD PORTFOLIO MANAGEMENT LLC, STATE STREET CORP; the top 25 are ranked at the top of this page.
Who are the major shareholders of RECURSION PHARMACEUTICALS IN?
The major shareholders of RECURSION PHARMACEUTICALS IN (RXRX) by reported 13F value are BlackRock Inc, Vanguard Group, ARK Invest, VANGUARD PORTFOLIO MANAGEMENT LLC, STATE STREET CORP, among 679 institutional holders.
Which legendary investors own RXRX?
1 of the legendary investors tracked on HoldingsHub report RXRX (RECURSION PHARMACEUTICALS IN) in their latest 13F filings, led by ARK Invest. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on RXRX?
1 tracked superinvestors hold RXRX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.